Drug Type Small molecule drug |
Synonyms AD 816, AD-816, AD816 |
Target |
Action inhibitors |
Mechanism NET inhibitors(Norepinephrine transporter inhibitors), Serotonin reuptake inhibitors |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC13H20ClNO3 |
InChIKeyHJOCKFVCMLCPTP-UHFFFAOYSA-N |
CAS Registry35604-67-2 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Sleep Apnea, Obstructive | Phase 2 | United States | 28 Apr 2023 |





